B cell responses to conjugate and polysaccharide meningococcal vaccines
<p>The primary approach to the control of meningococcal disease remains effective vaccination programmes in susceptible populations. Vaccines against serogroups A, C, W and Y offer broad protection against meningococci and both polysaccharide and conjugate quadrivalent vaccines are licensed fo...
Main Author: | Ramasamy, M |
---|---|
Other Authors: | Pollard, A |
Format: | Thesis |
Language: | English |
Published: |
2012
|
Subjects: |
Similar Items
-
Quadrivalent meningococcal conjugate vaccines
by: Pace, D, et al.
Published: (2009) -
Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America
by: Pollard, A, et al.
Published: (2004) -
Global epidemiology of meningococcal disease and vaccine efficacy
by: Pollard, A
Published: (2004) -
Impact of serogroup A meningococcal conjugate vaccine for Africa
by: James M. Stuart
Published: (2018-05-01) -
Maintaining protection against invasive bacteria with protein - polysaccharide conjugate vaccines
by: Pollard, A, et al.
Published: (2009)